Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person ATRX S213* [nucleoplasm]

Class:Id	EntityWithAccessionedSequence:9671255
_displayName	ATRX S213* [nucleoplasm]
_timestamp	2020-01-02 18:08:35
compartment	[Compartment:7660] nucleoplasm
created	[InstanceEdit:9671262] Orlic-Milacic, Marija, 2019-12-19
crossReference	[DatabaseIdentifier:9671285] COSMIC:COSV64875010
disease	[Disease:1500689] cancer [Disease:9659088] osteosarcoma
endCoordinate	212
hasModifiedResidue	[NonsenseMutation:9671251] Nonsense mutation at L-serine 213
literatureReference	[LiteratureReference:9671773] A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein
modified	[InstanceEdit:9671289] Orlic-Milacic, Marija, 2019-12-19 [InstanceEdit:9672763] Orlic-Milacic, Marija, 2020-01-02
name	ATRX S213* ATRX Ser213* ATRX S213TER ATRX Ser213TER
referenceEntity	[ReferenceGeneProduct:69817] UniProt:P46100 ATRX [Homo sapiens]
species	[Species:48887] Homo sapiens
stableIdentifier	[StableIdentifier:9671275] R-HSA-9671255.1
startCoordinate	1
(hasMember)	[CandidateSet:9670618] ATRX truncation mutants (DAXX binding region) [nucleoplasm] [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by ATRX S213* [nucleoplasm] (9671255)